发明申请
US20060062842A1 Method of administering a compound to multi-drug resistant cells
审中-公开
向多药耐药细胞施用化合物的方法
- 专利标题: Method of administering a compound to multi-drug resistant cells
- 专利标题(中): 向多药耐药细胞施用化合物的方法
-
申请号: US11220901申请日: 2005-09-06
-
公开(公告)号: US20060062842A1公开(公告)日: 2006-03-23
- 发明人: Alberto Gabizon , Samuel Zalipsky , Dorit Goren-Rubel , Aviva Horowitz
- 申请人: Alberto Gabizon , Samuel Zalipsky , Dorit Goren-Rubel , Aviva Horowitz
- 专利权人: Alza Corporation,Hadasit Medical Research and Development Ltd.
- 当前专利权人: Alza Corporation,Hadasit Medical Research and Development Ltd.
- 主分类号: A61K9/127
- IPC分类号: A61K9/127 ; A61K38/16 ; A61K31/704
摘要:
A composition for administration of a therapeutic compound to a multi-drug resistant cell in a person suffering from a drug-resistant cancer is described. The composition is composed of a carrier molecule and a folate targeting ligand, which is covalently attached to the carrier, and the therapeutic compound. In one preferred embodiment, the carrier is a liposome having a surface coating of hydrophilic polymer chains where a folate ligand is attached to the free distal end of at least a portion of the hydrophilic polymer chains, and the therapeutic agent is entrapped in the liposomes. The composition is effective to achieve accumulation of the therapeutic compound in the cell in an amount sufficient to be cytotoxic. Also described are methods for administering a therapeutic compound to a person suffering from a multi-drug resistant condition.
信息查询